LRSAM1 and familial pancreatic carcinoma: According to the previous study, FYN, LRSAM1, and SEMA6C serve as poor prognostic biomarkers in pancreatic cancer, whereas ERAP2, MET, IL20RB, and CXCL11 indicate improvements.